| Logo | Name | Σ |
|---|---|---|
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3674 |
 | Cosmetic Valley Cœur battant de l'industrie cosmétique mondiale - Beating heart of the world cosmetics industry Beating heart of the world cosmetics industry Recognized as a competitiveness cluster by the ministry in 2005, the role of Cosmetic Valley is to help fragrance and cosmetic industry in the sector, through: - Commercial development by networking, supporting exports for SMEs, - Improvement of their competitiveness : set-up of Research and Innovation projects. The cluster opens up to the whole of France: Cosmetic Valley gathered all companies in fragrance and cosmetic industry at national level. All companies who want to join a dynamic collaboration and … | 794 |
 | ANSM Agence nationale de sécurité du médicament et des produits de santé For safe, efficient, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public player who allows, on behalf of the State, access to health products in France and which ensures their safety throughout their life cycle. At the heart of the health system, we act at the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after its placing on the market. Through our assessments, expertise and our surveillance policy, we make sure … | 188 |
 | INRAE INRAE, National Institute for Research for Agriculture, Food and the Environment Inrae, the National Research Institute for Agriculture, Food and the Environment, is a major player in research and innovation created on January 1, 2020. A finalized research institute resulting from the merger between INRA and IRSTEA, INRAE brings together a community of 12,000 people, with just over 200 research units and around forty experimental units implanted in 18 centers. The Institute is positioned among the very first world leaders in agricultural and food sciences, in plants of plants and animals, and ranks 11th in ecology-environment. Inrae aims to be … Sectors: Research | 1702 |
 | BASF We create chemistry for a sustainable future At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Credits: https://www.basf.com/global/en/legal/credits Data … | 4153 |
 | Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: Pharmaceutical | 602 |